Academic Detailing Bill Could Be Interim Step To Comparative Effectiveness
Executive Summary
Congressional critics of pharmaceutical marketing practices launched another volley in their battle to curb industry influence on prescribers with the July 31 introduction of legislation that would create a federally-supported "academic detailing" program
You may also be interested in...
AHRQ Considers Academic Detailing To Distribute CER Findings
The Agency for Healthcare Research and Quality is considering "academic detailing" as a means of disseminating comparative effectiveness research findings to health care providers and recently took steps to gauge interest in such a program
AHRQ Considers Academic Detailing To Distribute CER Findings
The Agency for Healthcare Research and Quality is considering "academic detailing" as a means of disseminating comparative effectiveness research findings to health care providers and recently took steps to gauge interest in such a program
Sunshine Bill Trade-Off: Stronger Pre-emption Would Mean More Disclosure
Increased pre-emption under the Physician Payment Sunshine Act is possible if the federal law is expanded to include all or most provisions under state disclosure laws, Senate Finance Committee Investigative Counsel Christopher Armstrong said at the National Disclosure Summit in Washington, D.C